THZ1 (6 in Figure 2) is a potent CDK7 inhibitor that possesses an IC50 value of 3.2 nM for CDK7 and, also, inhibits CDK12 and CDK13 and shows antiproliferative activity on different cancer cell lines. Here, CDK7 is linked to cancer.